VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
SNDX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
SNDXSyndax Pharmaceuticals, Inc.
$17.64$1.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSNDXQuarterly Cash Flow

Syndax Pharmaceuticals, Inc. (SNDX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Syndax Pharmaceuticals, Inc. (SNDX) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

SNDX Cash Flow Statement

Quarterly statement

SNDX Cash Flow Statement

Syndax Pharmaceuticals, Inc. (SNDX) cash flow statement — 15-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-30.27M-50.34M-69.49M-70.53M-87.8M-95.16M-57.39M-62.32M-71.64M-83.55M-41.35M-44.65M-35.37M-39.23M-22.89M-28.54M-40.31M-41.93M100.71M-24.94M
Operating CF Margin %-41.59%-77.62%-101.47%-153.77%-231.3%-474.81%-747.24%-498.58%-2047%---------79.56%-201.57%
Operating CF Growth %65.52%47.1%-21.08%-13.18%-22.54%-13.9%-38.79%-39.57%-102.55%-112.98%-80.61%-56.44%12.24%6.45%-122.73%-14.43%-67.63%-85.63%744.29%-36.33%
Net Income-49.36M-42.67M-68.01M-60.72M-71.85M-84.85M-94.17M-84.13M-68.06M-72.4M-72.47M-51.15M-44.62M-41.13M-39.19M-35.4M-37.57M-37.17M96.2M-20.64M
Depreciation & Amortization5K4K3K-164K55K002K3K3K3K3K3K3K3K8K11K11K10K8K
Stock-Based Compensation14.01M12.05M11.25M12.08M13.79M10.38M12.3M11.93M9.9M8.9M8.33M8.32M8.06M6.24M4.24M4.36M3.94M3.48M3.93M3.38M
Deferred Taxes00000000000000000000
Other Non-Cash Items-18.71M-676K-973K1.64M-3.04M-3.27M-2.7M-2.76M-3.41M-3.58M-3.22M-3.42M-3.57M-3.86M-1.91M-145K-9K22K-690K401K
Working Capital Changes23.79M-19.05M-11.76M-23.38M-26.75M-17.43M27.19M12.63M-10.07M-16.47M26.01M1.59M4.75M-486K13.97M2.63M-6.67M-8.27M1.26M-8.1M
Change in Receivables-13.09M6.02M-19M-5.99M-3.77M-8.07M-6M4.35M-3.51M-6.07M0-3.9M3.97M01.06M8.56M-6.84M-6.26M00
Change in Inventory1.84M-2.06M-7.8M-7.18M-12.92M-4.19M00000000000000
Change in Payables-5.97M-5.74M2.75M-3.53M7.31M-1.58M6.73M-6.67M2.76M-1.15M3.91M-4.93M2.92M3.71M-2.76M676K-1.79M2.56M547K1.5M
Cash from Investing-16.91M38.39M81.58M72.43M41.89M94.14M-268.97M86.85M61.75M-99.4M-16.29M40.08M73.91M19.91M-137.63M-6.79M-49.95M8.18M-59.96M26.63M
Capital Expenditures-40K0-56K-131K0000000000000000
CapEx % of Revenue0.06%-0.08%0.29%----------------
Acquisitions00000000000000000000
Investments--------------------
Other Investing000000000000000225K00-129K0
Cash from Financing252.77M7.92M5.92M6.28M551K930K347.43M3.1M676K2.17M258.48M1.85M1.32M2.47M163.5M-13.53M21.72M557K109.78M1.71M
Debt Issued (Net)250M00000000000002K00000
Equity Issued (Net)8.3M7.92M5.92M6.28M551K00000258.09M000162.36M00081.21M0
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-5.53M0000930K347.43M3.1M676K2.17M389K1.85M1.32M2.47M1.14M-13.53M21.72M557K28.57M1.71M
Net Change in Cash205.58M-4.04M18.01M8.17M-45.36M-90K21.06M27.62M-9.22M-180.78M200.84M-2.73M39.86M-16.84M2.98M-48.86M-68.53M-33.19M150.53M3.39M
Free Cash Flow-30.31M-50.34M-69.54M-70.67M-87.8M-95.16M-57.39M-62.32M-71.64M-83.55M-41.35M-44.65M-35.37M-39.23M-22.89M-28.54M-40.31M-41.93M100.58M-24.94M
FCF Margin %-41.64%-77.62%-101.55%-154.05%-231.3%-474.81%-747.24%-498.58%-2047%---------79.46%-201.57%
FCF Growth %65.47%47.1%-21.18%-13.39%-22.54%-13.9%-38.79%-39.57%-102.55%-112.98%-80.61%-56.44%12.24%6.45%-122.76%-14.43%-67.63%-85.63%743.46%-36.33%
FCF per Share-0.34-0.58-0.80-0.82-1.02-1.11-0.67-0.73-0.84-0.98-0.57-0.64-0.51-0.56-0.36-0.47-0.67-0.711.89-0.48
FCF Conversion (FCF/Net Income)0.61x1.18x1.02x1.16x1.22x1.12x0.61x0.74x1.05x1.15x0.57x0.87x0.79x0.95x0.58x0.81x1.07x1.13x1.05x1.21x
Interest Paid0000000000000001.1M490K470K0503K
Taxes Paid00000000000000000000